This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

Volume: 11, Issue: 1
Published: Jul 2, 2021
Abstract
In metastatic breast cancer (mBC), the change of human epidermal growth factor receptor 2 (HER2) status between primary and metastatic lesions is widely recognized, however clinical implications are unknown. Our study address the question if relevant differences exist between subjects who preserve the HER2 status and those who gain the HER2 positivity when relapsed. Data of patients affected by HER2-positive mBC, treated with pertuzumab and/or...
Paper Details
Title
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
Published Date
Jul 2, 2021
Volume
11
Issue
1
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.